Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Blood Specimen Collection × Plasma cell × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 4 Tumor-Agnostic 2 Plasma cell 1 Dermatologic 1

Conditions

Multiple Myeloma 19 Lymphoma 5 Neoplasms, Plasma Cell 4 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Hodgkin Disease 2 Sarcoma 1 Paraproteinemias 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Immunoglobulin Light-chain Amyloidosis 1 Immunoblastic Lymphadenopathy 1 Hematologic Neoplasms 1 Disease 1 Carcinoma 1 Amyloidosis 1 Alzheimer Disease 1

Interventions

Lenalidomide 5 Dexamethasone 4 fludarabine phosphate 2 daratumumab 2 Whole-Body Irradiation 2 Cyclophosphamide 2 Calcium Dobesilate 2 talquetamab 1 selinexor 1 ixazomib 1 isatuximab 1 fludarabine 1 Transplantation, Autologous 1 Sirolimus 1 Rituximab 1 Mycophenolic Acid 1 Melphalan 1 Bortezomib 1 Blood Specimen Collection 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02627261 2022-09-06

MMRD

Hospices Civils de Lyon

Multiple Myeloma, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡